Details of the Drug

General Information of Drug (ID: DMMTL7V)

Drug Name
Hemoglobin raffimer
Synonyms Hemolink; Cross-linked hemoglobin, Hemosol
Indication
Disease Entry ICD 11 Status REF
Anemia 3A00-3A9Z Phase 2/3 [1]
Cross-matching ID
DrugBank ID
DB13658
TTD ID
D0H4CB

Molecular Interaction Atlas of This Drug


Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Hemoglobin (HB) TTQO71U HBA_HUMAN Modulator [2]
Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This Drug

References

1 ClinicalTrials.gov (NCT00038454) Phase II Study To Evaluate The Safety and Efficacy of Hemoglobin Raffimer in Patients Undergoing First Time CABG Surgery. U.S. National Institutes of Health.
2 Use of hemoglobin raffimer for postoperative life-threatening anemia in a Jehovah's Witness. Can J Anaesth. 2005 Apr;52(4):369-73.